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Summary 
Extracenular  matrix (ECM) molecules such as fibronectin  (FN), collagens, and laminin have 
important roles in hematopoiesis.  However, little is known about the precise mechanisms by 
which ECM molecules regulate proliferation of human hematopoietic progenitor ceils. In this 
study, we have investigated the effects of ECM molecules, particularly of FN, on the proliferation 
of  a  myeloid leukemia cell  line,  MOTE, which  proliferates  in  response  to  either  human 
granulocyte/macrophage colony-stimulating factor (GM-CSF)  or stem cell factor (SCF). The 
[SH]thymidine incorporation and cell enumeration assays showed that FN strikingly inhibited 
GM-CSF- or SCF-induced proliferation  of MO7E cells in a dose-dependent  manner, whereas 
little or no inhibition was induced by collagen types I and IV. The growth suppression of MO7E 
cells was not due to the inhibitory effect of FN on ligand binding or very early events in the 
signal transduction pathways from the GM-CSF or SCF receptors. DNA content analysis using 
flow cytometry after staining with propidium iodide revealed that the treatment of MO7E cells 
with FN did not block the entry of the cells into the cell cycle after stimulation with GM-CSF 
or SCF, whereas the treatment resulted in the appearance of subdiploid peak. Furthermore, FN 
was found to induce oligonudeosomal DNA fragmentation and chromatin condensation in the 
cdls even in the presence of GM-CSF or SCF, suggesting the involvement of programmed cell 
death (apoptosis) in the FN-induced growth suppression. The growth suppression or apoptosis 
induced by FN was rescued by the addition of either anti-FN antibody,  anti-very late antigen 
5 monodonal antibody (anti-VLA5 mAb), or GKGDSP peptide, but not by that of anti-VLA4 
mAb or GRGESP peptide, suggesting that the FN effects on MO7E ceils were mediated through 
VLA5. In addition, the 1  N-induced apoptosis was detectable  in VLA5-positive human hematopoietic 
cell lines other than MO7E ceils, but not in any of the VLA5-negative cell lines. These results 
suggest that FN is capable of inducing apoptosis via its interaction with VLA5, and also raise 
the possibility that the FN-VLA5 interaction may contribute, at least in part, to negative regulation 
of hematopoiesis. 
N 
'ormal hematopoiesis is regulated by a complex set of 
events, involving interactions of hematopoietic stem cells 
with bone marrow stromal cells and/or extraceilular matrix 
(ECM) 1 molecules (1--4). Because of a variety of hematopoi- 
etic growth factors being produced by stromal cells, it has 
been suggested that these growth factors may play a role in 
1 Abbreviations used in  this paper: ECM,  txtracellular  matrix;  FN, 
fibronectin;  KitR., c-kit receptor; PI, propidium iodide; SCF, stem cell 
factor; VLA, very late antigen. 
stromal  cell-mediated hematopoiesis  (5-7).  In fact,  some 
growth factors such as stem cell factor (SCF) and M-CSF 
are produced by stromal ceils as either membrane bound or 
soluble forms, and are considered to be indispensable mole- 
cules for stromal cell-dependeut proliferation and differenti- 
ation of hematopoietic calls (8-13).  Furthermore, growth 
factors such as GM-CSF are reported to be capable of binding 
to ECM, and are proposed to function to promote growth 
of hematopoietic ceils (14, 15). 
In addition to hematopoietic growth factors, ECM such 
as fibronectin (PN), collagens, larninin, thrombospondin,  and 
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mote growth, differentiation,  anchorage, spreading, and migra- 
tion of hematopoietic cells (for reviews see references 16-22). 
Cell surface receptors for ECM molecules are the integrins 
that are c~//3 heterodimeric tran.~raembrane glycoproteins;  they 
are subdivided according to their common/3 chain subunit 
into at least eight classes (18-22). A number of studies have 
demonstrated that integrins of the/31 subfamily, also known 
as very late antigen (VLA), are primarily responsible for the 
celI-ECM interactions,  whereas those of the/32  subfamily 
are the mediators of ceil-cell and cell-endothelial interactions 
(18-22). Among ceI1-ECM interactions, VLA-4/FN (CS-1 
region) or VLA-5/FN (ILGDS sequence) interactions  have 
been proposed to have potentially crucial roles in the attach- 
ment, migration, or differentiation of hematopoietic progen- 
itor cells (20, 21, 23-29). For e~ample, progenitors of erythroid 
or lymphoid lineages attach to FN, but differentiated cells 
of these lineages become unable to adhere to FN because of 
their loss of FN-receptor expression (26-29). In addition, adhe- 
sion of CD4- CD8- T cells to thymic stroma cells through 
FN-FN receptor interaction is considered to be crucial for 
their differentiation  (30).  Furthermore,  the interaction be- 
tween FN and VLA4 was demonstrated to play a rdevant 
role in the terminal  differentiation  of human  B cells  (31), 
whereas FN was reported to inhibit suspension-induced ter- 
minal differentiation of human keratinocytes via a/31 inte- 
grin, probably VLA5 (32). However, little is known about 
the effects of ECM molecules on the proliferation of hema- 
topoietic progenitor cells, especially of human myeloid pro- 
genitor ceUs. 
In an effort to investigate the effects of ECM molecules 
on human hematopoietic progenitor cells, we have primarily 
used a human mydoid cell line, M07E (33), because this cell 
line shows about the same proliferative response to GM-CSF 
or SCF as normal mydoid progenitor cells (34-36), and ex- 
presses several/31 integrins, including VLA2, VLA4, VLA5, 
and VLA6 (37). Also, the assay system deprived of signaling 
between various cell types makes it possible to determine the 
direct effect of ECM molecules on hematopoietic cells.  Of 
several ECM molecules tested, FN was found to dramatically 
induce programed cell death (apoptosis), resulting in inhibi- 
tion of GM-CSF- or SCF-dependent proliferation of M07E 
cells. The FN-induced apoptosis or growth suppression was 
rescued by the treatment  with either anti-FN  serum,  anti- 
VLA5 mAb or GR.GDSP peptide, but not with anti-VLA4 
mAb or GRGESP peptide, suggesting that VLA5-FN inter- 
action may be involved in the effect of FN. Thus,  our data 
provide unique evidence for the role of VLA5-FN interac- 
tion in the growth regulation  of hematopoietic cells. 
Materiah and Methods 
Reagents and Antibodies.  Highly purified recombinant human 
GM-CSF was a gift from Drs.  Steve Clark  and Gordon Wong 
(Genetics Institute,  Cambridge, MA). Recombinant human SCF 
was a gift from Dr. Krisztina M. Zsebo (Amgen, Inc., Thousand 
Oaks, CA) (10). Human plasma FN was purchased from Collabora- 
tive Biomedical Products (Bedford, MA). Murine mAbs reactive 
with CD49d/VLA4-ol (SG17 and IgG2a) and CD49e/VLAS-c~ 
(Ird-I72 and IgG1) were kind gifts of Dr. Kensuke Miyake (Saga 
Medical School, Saga, Japan) (38). The anti-phosphotyrosine anti- 
body, a murine  mAb generated against phosphotyramine  as the 
immunogen,  was generously supplied by Dr. Brian Druker (Dana- 
Farber Cancer Institute,  Boston, MA) (34, 35). Goat F(ab')2 an- 
tibodies against human FN, mouse IgG, and purified murine my- 
eloma proteins of IgG1 (MOPC21) and IgG2a (UPC10) isotypes 
were purchased from Cappel (Durham,  NC). Synthetic peptides 
GRGDSP and GRGESP were purchased from Iwaki Glass (Tokyo, 
Japan). Chemically defined serum-free medium ASF-102 was pur- 
chased from Ajinomoto (Tokyo, Japan). It contains human trans- 
ferrin,  insulin,  and BSA. 
Source of Cells.  A human GM-CSF, IL-3, and SCF-dependent 
cell line, MO7E, obtained from Dr.  Steve Clark  (Genetics Insti- 
tute), was originally established by Avanzi et al. (33) from the pe- 
ripheral blood of an infant with acute megakaryocytic leukemia. 
M07E cells were cultured in RPMI-1640 medium (Nacalai Tesque, 
Kyoto, Japan) supplemented with 10% FCS (Flow Laboratories, 
North Ryde, Australia) and 10 ng/ml rhGM-CSF. Myeloid leukemia 
cell lines (HL-60, KG1, THPI, and KU812F), erythroid leukemia 
cell lines (K562 and HEL), T cell leukemia cell lines (CCRF-CEM 
and MOLT-3), B cell leukemia cell lines (BALL and RPMI-1788), 
and a human fetus-derived fibroblast cell line (NTI4) were obtained 
from the Japanese Cancer Research Resources Bank (Tokyo,  Japan). 
These cell fines were adapted to grow and were maintained in RPMI- 
1640 supplemented with 10% FCS. OTL-1 cell line was established 
in our laboratory from the peripheral blood of a patient with adult 
T cell leukemia, and maintained in RPMI-1640 supplemented with 
10% FCS. 
Peripheral blood was collected from healthy volunteers after ob- 
taining informed consent. PBMC were isolated by Ficoll-Hypaque 
gradient centrifugation  (Lymphoprep; Nycomed, Oslo, Norway), 
and PBL were obtained after depleting  monocytes by adherence 
to plastic dishes for 3 h at 37~  Neutrophils were obtained from 
peripheral blood by double Ficoll-Hypaque gradient method as de- 
scribed previously (39). Both lymphocyte and neutrophil prepara- 
tions  were  >95%  pure  as  assessed by May-Grunwald-Giemsa 
staining. 
CellProliferation Assay.  To quantitate the proliferation of cells, 
we used a [3H]thymidine incorporation  assay as previously de- 
scribed (35, 36). In the proliferation assay, both soluble and im- 
mobilized ECM were used. For immobilization,  flat-bottom,  96- 
well microtiter  wells were incubated first with either  100/~1 of 
FN (0-100/zg in PB$) or 1% BSA for 1 h at 37~  and the wells 
were washed with PBS and further  incubated with 1% BSA to 
block nonspecific protein binding sites. In this study, however, we 
used soluble FN in most experiments because of the following 
reasons: (a) in preliminary studies, it was noted that growth sup- 
pression and apoptosis of M07E cells were significantly induced 
not only by immobilized FN but also by soluble FN; and (b) it 
seemed rather  di~cult to estimate the amounts  of FN immobi- 
lized after incubation.  Cells were washed  twice with ASF-102 
medium,  and the triplicate aliquots of the cells (3  x  104 cells in 
100/zl of ASF-102 medium) were cultured in 96-well, flat bottom 
microtiter  plates with various combinations  of GM-CSF, SCF, 
ECM, and/or antibodies. At various times after the initiation  of 
culture, each well was pulsed for 5 h with 0.5/zCi [3H]thymidine 
(sp act, 5 Ci/mM; Amersham International,  Amersham,  Bucks, 
UK). The cells were then harvested with a semiautomatic cell har- 
vester (model 1295; Pharmacia LKB Biotechnology,  Hscataway, 
NJ) and the incorporation was measured with a liquid scintillation 
counter. 
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enumeration: viable cells were counted either by trypan blue dye 
exclusion or a phase-contrast microscope with a standard hemo- 
cytometer. In addition, the morphological  characteristics  of the cells 
were determined by staining the cytospin preparations (Shandon, 
Pittsburgh,  PA) with May-Grunwald-Giemsa. 
Flow Cytometry,  Nuclear  DNA content and cell  cycle  were ana- 
lyzed by flow cytometry as described previously (40). Briefy, cells 
were centrifuged, the cell pellet was gently resuspended in hypo- 
tonic fluorochrome solution (50 ~g/ml of propidium iodide [PI] 
in 0.1% sodium citrate containing 0.1% Triton X-100), and the 
ceils were incubated at 4~  overnight in the dark. The fluores- 
cence emitted from the PI-DNA complex was then quantitated 
after laser  e~z'itation  of the fluorescence  dye by a FACScan  |  (Becton 
Dickinson & Co., Mountain View, CA). 
To examine  the surface expression of VLAs, ceils  were incubated 
with the indicated antibodies at 4~  for 30 min, rinsed, and devel- 
oped with FITC-conjugated goat anti-mouse IgG (Becton Dick- 
inson & Co.) at 4~  for 30 min. The ceils were then rinsed and 
analyzed on a FACScan  | 
Analysis of DNA Fragmentation.  Fragmentation of DNA was 
analyzed as described previously  (41). Ceils were incubated for the 
indicated time periods under various culture conditions. After in- 
cubation, the ceils  were washed twice in PBS and immediately  used 
for DNA extraction. Equal numbers of the cells were lysed in a 
lysis  solution  com~inlng  200 mM Tris-HCl,  pH 8.0, 100 mM EDTA, 
1% SDS, and 50 pg/ml protdnase K (Nacalai Tesque). After a 4-h 
incubation at 37~  with constant rotation, DNA was extracted 
with an equal volume of Tris buffer-saturated phenol and chloro- 
form/isoamylalcohol (24:1). The aqueous phase was mixed with 
sodium chloride to give a final  concentration of 150 mM of sodium 
chloride, followed  by addition of 2 vol absolute ethanol. The mix- 
ture was incubated  at - 20~  overnight, and the ethanol-precipitated 
DNA was dried and resuspended in TE (10 mM Tris-HCl and 1 
mM EDTA) buffer. The suspension was treated with 50/~g/ml 
of DNase-free KNase for 5 h at 37~  and then with 300/zg/ml 
proteinase K for 5 h at 37~  DNA was precipitated again by eth- 
anol and resuspended in TE buffer. Subsequently, 5 #g DNA per 
lane was separated by electrophoresis on a 1% agarose gel in the 
presence of  ethidium bromide. The dectrophoresis was carried out 
in TBE buffer (90 mM Tris-HC1, 90 mM boric add, and 2 mM 
Er~_A). 
Stimulation with Factors and Cell Lysis.  Exponentially growing 
M07E cells were washed free of serum and growth factors and in- 
cubated in serum-free  ASF-102 medium for 12 h at 37~  to factor 
deprive the cells. The cells (10  ~ ceils suspended in 1 ml of ASF- 
102 medium) were treated with FN (50 #g/ml) at 37~  for 20 
min, and then exposed to GM-CSF (10 ng/ml) or SCF (100 ng/ml) 
at 37~  for 15 min. After stimulation  with factors,  cells  were washed 
with cold PBS and lysed in lysis  buffer (20 mM Tris-HC1, pH 8.0, 
137 mM NaC1, 10% glycerol, 1% NP-40) containing protease and 
phosphatase inhibitors as described previously (34, 42). Insoluble 
material was removed by centrifugation at 10,000 g for 15 min at 
4~ 
Gel Electrophoresis and Immunoblotting.  The procedures of gel 
dectrophoresis and immunoblotting were performed according to 
the methods described previously (34, 42, 43). Briefly,  ceil lysates 
(150 #g for 13x  12-cm  gds) were mixed 2:1 with 3x SDS-sample 
buffer with 2-ME, heated  at 100~  for 5 rain before  one-dimensional 
SDS-PAGE with 7.5% polyacrylamide.  After electrophoresis, pro- 
teins were electrophoreticaily  transferred from the gel onto a poly- 
vinylidene difluoride membrane (Immobilon; Millipore, Bedford, 
MA) in a buffer containing 25 mM T_ris, 192 mM glycine,  and 20% 
methanol at 0.4 A for 4 h at 4~  Residual binding sites on the 
filter were blocked by incubating the membrane in TBS (10 mM 
Tris-HCl, pH 8.0, 150 mM NaC1) containing 1% gelatin (Bio- 
Pad Laboratories, Richmond, CA) for 1 h at 25~  Immunoblot- 
ring was then performed with anti-phosphotyrosine mAb  (1.5 
/~g/ml)  and  alkaline phosphatase-conjugated  anti-mouse  IgG 
(Promega Corp., Madison, WI). 
Results 
FN Is Inhibitory to the Proliferation of  MOTE Cells Stimulated 
with GM-CSF orSCE  We first examined the effects of var- 
ious ECM molecules on GM-CSF-induced proliferation of 
M07E ceils. M07E cells were cultured in a serum-free medium 
containing GM-CSF (10 ng/ml) in the presence  or absence 
of collagen type I, collagen type IV, laminin, or FN (each 
at a concentration of 25 Izg/ml) for 3 d, followed by mea- 
surement of cell proliferation with a [3H]thymidine incor- 
poration assay. Despite little effect by collagen types I and 
IV, GM-CSF-induced proliferation of M07E cells was fig- 
nificantly suppressed by laminin and particttlarly by FN (Fig. 
1).  These suppressive  effects were also observed  using ira- 
mobilized forms of laminin and FN, albeit to a lesser degree 
than soluble forms (data not shown). 
Since the most striking inhibition was observed by FN, 
we examined the dose-response effect of FN and GM-CSF 
and SCF-induced proliferation of M07E cells. The [3H]thy- 
midine incorporation assay  showed that FN inhibited GM-CSF 
or SCF-induced proliferation of  M07E cells in a dose-dependent 
manner (Fig. 2 A). In addition, the time course study showed 
that FN (50 Izg/ml) inhibited the GM-CSF- or SCF-induced 
proliferation of M07E ceils throughout the culture period 
(Fig.  2 B). In addition to the [3H]thymidine incorporation 
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Figure 1.  Effect  of ECM molecules  on proliferation  of M073 cells. Tripli- 
cate aliquots of M073 cells (3 x 104) were incubated  for 72 h in a serum- 
free AFS102 medium containing 10 ng/ml of GM-CSF in the presence 
of tither collagen type I, collagen type IV, hminin, or fibronectin  (all 
25 ~g/ml). The cells were pulsed for the final  5 h of 72-h culture period 
with 0.5/~Ci [3H]thymidine;  [3H]thymidine  incorporation  was measured 
with a liquid  scintillation  counter; and percent control  was measured. The 
results are shown as mean •  SD of three independent ~periments. 
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Figure 2.  Effects  of FN on proliferation of M073 cells. (A) Triplicate 
aliquots of M073 cells (3  x  104) were incubated for 72 h in a serum-free 
medium containing control media, GM-CSF (10 ng/ml) or SCF (100 ng/ml) 
with the indicated concentrations of FN. (B) Triplicate aliquots of M073 
cells were incubated with or without 50 #g/m1 of FN in the presence 
or absence of GM-CSF (10 ng/ml) or SCF (100 ng/ml) for the indicated 
times. Cell proliferation was measured using a [aH]thymidine incorpora- 
tion assay. The results are shown as mean _+  SD of triplicate cultures. 
assay, the inhibitory effect of FN on M07E proliferation was 
assessed by cell enumeration method. Inconsistent with the 
data on [3H]thymidine incorporation, FN almost completely 
inhibited the GM-CSF-- or SCF-induced proliferation of M07E 
cells (Fig. 3 A). Moreover, it was revealed that FN treatment 
led to a decrease in the proportion of viable cells in the pres- 
ence or absence of GM-CSF or SCF (Pig.  3 B). 
Effect of FN on the Initial Signaling Mediated by GM-CSF 
or SCE  One of the possible mechanisms that might explain 
the suppressive effect of FN was that FN inhibited the binding 
of GM-CSF or SCF to the corresponding receptor, thereby 
blocking the initial signaling of GM-CSF or SCE By using 
M07E cells, we have previously demonstrated that GM-CSF 
and SCF induce rapid, dose-dependent tyrosine phosphory- 
lation of a 93-kD cytoplasmic protein (p93) (34, 35) and the 
145-kD c-kit receptor (KitR) (36, 43), respectively, and also 
that the tyrosine phosphorylation  of p93 or K.itR is correlated 
with the rate of cell proliferation (34-36). We therefore de- 
termined whether FN inhibited tyrosine phosphorylation of 
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Figure 3.  Effects  of FN on viable cell number and viability of M073 
cells. Triplicate  aliquots of M073 cells  were incubated in a serum-free  medium 
containing  control media, GM-CSF (10 ng/ml), or SCF (100 ng/ud) with 
or without 50/~g/ml of FN for the indicated times. At various times after 
initiation  of the culture, viable cell number (A) and viability  (/3) of M073 
cells were determined by trypan blue dye exclusion, a phase-contrast mi- 
croscope, and May-Grunwald-Giemsa staining. The results are shown as 
mean •  SD of triplicate cultures. 
p93 or Kirk in M07E cellg M07E cells were deprived of factor 
for 12 h, pretreated with 50/~g/ml of FN or control media 
for 20 rain, and then further cultured with control media, 
GM-CSF,  or SCF for an additional 15 min. The cells were 
then lysed and phosphotyrosine-containing  proteins detected 
by immunoblotting. The pretreatment of M07E cells with 
FN did not affect tyrosine phosphorylation of p93 and KitR 
(c-k/t) whose phosphorylation was induced by GM-CSF and 
SCF, respectively (Fig. 4). Further, tyrosine phosphorylation 
of p93 and KitR was not inhibited even after long-term ex- 
posure to FN (up to 12 h). These results suggest that FN 
is inhibitory to neither ligand binding nor very early steps 
in the signal transduction pathways  from the GM-CSF or 
SCF receptors. 
FN Induces Apoptosis.  To further understand the mecha- 
nism by which FN inhibited the factor-dependent prolifera- 
tion of M07E ceils, we investigated the effect of FN on the 
state of cell cycle in M07E ceUs. In the presence or absence 
of FN (50 #g/ml), M07E cells were cultured in a serum-frec 
media containing medium alone, GM-CSF, or SCF for 36 h, 
and the ceils were stained with PI and analyzed by flow cytom- 
etry.  As shown in Fig.  5 A, FN treatment did not block 
the entry of M07E ceils into the cell cycle when stimulated 
with GM-CSF or SCF. However, the treatment ofM07E ceUs 
with FN resulted in the appearance  of subdiploid peak in 
1760  Involvement of VLA5 in Fibronectin-induced Apoptosis Hgure  4.  Effects of FN on factor-induced protein tyrosine phosphory- 
lation. M07E ~lls were factor deprived  for 12 h, exposed to FN (50/~g/ral) 
or control media for 20 rain, and then further cultured with control media, 
GM-CSF (10 ng/ml), and SCF (100 ng/ml) for an additional 15 min. The 
cells were then lysed and phosphotyrosine-contalning proteins were de- 
tected by immunoblotting with an anti-phosphotyrosine mAb. (Right) 
The mobilities of p93 and KitR (c-k/t). 
the presence or absence of stimulation with GM-CSF or SCF 
(Fig. 5 A). Moreover, the DNA content analysis revealed that 
the proportions of subdiploid peak were 17.8, 55.3, and 52.6% 
after the treatment with FN (50/~g/ml) and GM-CSF (10 
ng/ml) for 24, 48, and 72 h, respectively, raising the possi- 
bility that the FN-induced cell death observed in Fig.  3 B 
was due to apoptosis. 
To test this possibility,  M07E cells were treated with or 
without FN, and subjected to DNA fragmentation and mor- 
phological analyses. In the absence of FN, DNA fragmenta- 
tion was barely detected in M07E ceils when cultured with 
GM-CSF or SCF, whereas factor deprivation induced DNA 
fragmentation to a modest degree (Fig.  5 B). By contrast, 
DNA fragmentation into oligonucleosomal-sized  pieces was 
readily visible after the treatment with FN even in the pres- 
ence of GM-CSF or SCF (Fig. 5 B). FN treatment was also 
found to lead to distinctive condensation of chromatin and 
fragmented nuclei (Fig.  5 C).  These results indicated that 
FN induced apoptosis of  M07E cells, thereby leading to growth 
suppression of the ceils. 
Involvement of VLA5 in the Effect of FN.  Interaction of 
hematopoietic cells with FN is known to be mediated by 
at least two integrins, VLA4 and VLA5, which recognize 
the CS-1 region and RGDS sequence of PN, respectively (18, 
20-24). The expression of VLA4 and VLA5 on M07E cells 
was examined by flow cytometry using anti-VLA4-o~ (SG17) 
and anti-VLAS-ex (KH72) mAbs. This analysis showed that 
VLA4 and VLA5 were abundantly expressed on the cell sur- 
face of M07E ceUs at an almost equal level (Fig.  6). 
To determine whether each integrin expressed on M07E 
cells was involved in the FN effects, M07E cells were cul- 
tured with GM-CSF (10 ng/ml) and FN (15 #g/ml) in the 
presence of anti-VLA4 mAb, anti-VLA5 mAb, anti-FN Ab, 
or RGD-containing peptide. The thymidine incorporation 
1761  Sugaharaet ~. 
Figure  5.  Induction of oligunudeosomal  DNA fragmentation and chro- 
matin condensation by FN. M073  cells were incubated in a serum-free 
medium containing control media, GM-CSF (10 ng/ml),  or SCF (100 
ng/ml) with or without 50/tg/ml of FN for 36 h, and then subjected 
to nuclear DNA content (A), DNA fragmentation (B), and morpholog- 
ical (C) analyses as described in Materials and Methods. Exponentially 
growing M07E cells that were cultured with GM-CSP (10 ng/ml) were 
used as Control (B and (C). Each figure shows one of three similar ~- 
tmtiments. 
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Figure  6.  Expression  of VLA4 and VLA5 on M07E cells. The cells 
were incubated in either negative control antibody (- - -) or the indicated 
anti-VLA-~x  mAb (-), washed, incubated with fluorescein-conjugated goat 
F(ab')2 anti-mouse IgG antibody, and analyzed on a FACScan  |  Anti- 
V'LA4-ot (SG17 and IgG2a) and anti-VLA5oe (KI-172  and lgG1) were used 
in this study. assay showed that, when compared with controls, the sup- 
pressive effect of FN on GM-CSF-induced prolift~ration of 
M07E cells was significantly rescued by the addition of ei- 
ther anti-FN-antibody or anti-VLA5-a mAb, but not anti- 
VLA4-a mAb (Fig. 7 A). Also, the growth suppression in- 
duced by FN was considerably abrogated by the incubation 
with GRGDSP peptide but not with GRGESP peptide (Fig. 
7 A). In accord with data on the proliferation assay, further, 
FN-induced apoptosis of M07E cells was canceled by incuba- 
tion with either anti-FN-antibody, anti-VLA5-oe mAb, or 
A  Growth Suppression 
anti-VLA4 
Mouse IgG2a 
anti-VLA5 
Mouse IgG1 
GRGDSP 
GRGESP 
Goat anti-FN 
Goat anti- 
Mouse IgG 
-20 
B  Apoptosis 
anti-VLA4 
Mouse IgG2a  ~ 
anti-VLA5 
Mouse IgG1 
GRGDSP 
GRGESP 
Goat anti-FN 
Goat anti- 
Mouse IgG  . 
-20 
0  20  40  60  80 
%Inhibition 
0  20  40  60  80 
%Inhibition 
Figure  7.  Involvement of VLA5 in the growth suppression  (A) and 
apoptosis (B) of M07E ceils by FN. (A) Triplicate aliquots of M073 cells 
(3  x  104) were cultured in a serum-free  medium containing GM-CSF 
(10 ng/ml) with or without FN (15/~g/ml) for 72 h in the presence or 
absence of the indicated antibodies or peptides, and cell proliferation was 
measured using a [3H]thymidine incorporation assay. Shown are percent 
inhibition by the indicated antibodies or peptides of FN-induced growth 
suppression. (/3) Triplicate aliquots of M073 cells (2  x  10  s) were cultured 
with FN (50 izg/ml) for 48 h as described above, and percent inhibition 
by the indicated antibodies or peptides of FN-induced apoptosis was mea- 
sured. In this study, the cells in apoptosis were determined by DNA con- 
tent analysis (36). The concentrations of antibodies and peptides used in 
these studies were as follows: anti-VLA4 mAb, anti-VLA5 mAb, and their 
control mAbs of mouse lgG1 and IgG2a isotypes were used at 50/~g/ml; 
goat anti-FN and anti-mouse IgG antibodies at 0.5 mg/ml; and GKGDSP 
and GRGESP peptides at 0.5 mg/ml. All of the results are shown as mean 
•  SD of triplicate cultures. 
GRGDSP  peptide,  but  not  with  anti-VLA4-a  mAb  or 
GRGESP peptide (Fig.  7 B). Similar results were also ob- 
tained with SCF (data not shown). These results suggested 
that FN exhibited the growth suppression or apoptosis, at 
least in part, via its interaction with VLA5 expressed on MO7E 
ceils. 
Effect of FN on Various Types of Cells.  Using flow cytom- 
etry analysis, the expression of VLA4 and VLA5 was exam- 
ined on a variety of human hematopoietic cell lines including 
myeloid cell  lines  (HL-60,  KG1,  THP-1,  and  KU812F), 
erythroid cell lines (K562 and HEL), T  cell lines (CCRF- 
CEM, MOLT-3, and OTL-1) and B cell lines (BALL and 
RPMI1788), and also on a human fibroblast cell line (NTI4) 
as a control for non-hematopoietic  cells. In addition, we ana- 
lyzed the expression of VLA4 and VLA5 on PBL and neu- 
trophils. In hematopoietic cell lines, VLA4 and VLA5 were 
easily detectable on all but three cell lines tested. OTL-1, BALL, 
and RPMI1788, expressed only VLA4 on their surface (Table 
1). In NTI4 cells, VLA5 was readily detectable on their sur- 
face, whereas VLA4 was expressed on only a minor popula- 
tion of the cells (Table 1). Furthermore, both VLA4 and VLA5 
were expressed on PBL, but neither of them was expressed 
on neutrophils (Table 1). 
To examine the effects of FN on these ceils, cells were cul- 
tured in a serum-free medium containing FN (50/~g/ml), 
and subjected to proliferation and apoptosis assays. In the he- 
matopoietic cell lines, the proliferation of VLAS-positive cell 
lines was inhibited by incubation with FN, whereas prolifer- 
ation of VLA5-negative cell lines  was rather  stimulated. 
Moreover, although the proportion of apoptosis was not n~es- 
sarily correlated with the rate of the growth suppression, apop- 
tosis was found to be induced by the treatment with FN in 
most, ff not all, of the VLAS-positive cell lines (Table 1). 
In addition, the FN-induced growth suppression and apop- 
tosis were also observed in PBL, although FN had no effects 
on neutrophils that were used as a negative control. By con- 
trast, growth suppression or apoptosis by FN was only min- 
imal or absent in NTI4 cells (Table 1). These results showed 
that the growth inhibition or apoptosis induced by FN was 
not limited to MO7E cells but was detectable in at least some 
of the other VLA5-positive hematopoietic cells, whereas 
VLA5-negative hematopoietic cells showed neither growth 
suppression nor apoptosis in response to FN. 
Discussion 
FN, a ubiquitous glycoprotein that can be produced by 
many types of cells such as fibrobhsts, endothdial cells, and 
macrophages, has been implicated as an important molecule 
for the attachment of hematopoietic stem or progenitor cells 
(for reviews see references 17, 21, 22, 26-29). However, the 
role of FN in growth regulation of hematopoietic stem or 
progenitor cells is largely unknown. In this study, we found 
that FN inhibited GM-CSF- or SCF-dependent proliferation 
of MOTE cells  in both  thymidine incorporation and cell 
enumeration assays, whereas little or no effect was observed 
with collagen types I and IV. The inhibitory effect of FN 
on GM-CSF- or SCF-induced proliferation of MOTE cells 
1762  Involvement  of VLA5 in Fibronectin-induced Apoptosis Table  1.  The Expression of VLA4 and VLA5 lntegrins, and the Effects of FN on the Proliferation and Apoptosis of Human Cell Lines 
and Leukoq/tes 
Expression  Effects of FN* 
Cells  VLA4  VLA5  Proliferation  (SI)  Apoptosis 
%  % 
Hematopoietic 
cell  lines 
Myeloid 
M07E  99.5  99.7  0.20'  40.1s 
HL60  99.7  95.4  0.40  33.7 
KG1  98.2  99.5  0.21  19.3 
THP1  99.7  99.9  0.23  23.7 
KU812F  94.5  97.6  0.19  33.5 
Erythroid 
K562  91.8  99.6  0.51  15.7 
HEL  99.6  99.6  0.29  11.3 
T  cell 
CCRF-CEM  99.3  84.1  0.46  29.3 
MOLT-3  99.7  74.1  0.43  21.3 
OTL-1  98.8  0.4  1.25  2.9 
B cell 
BALL  99.9  9.9  1.10  3.6 
RPMI-1788  92.8  1.1  1.39  2.1 
Fibroblast 
cell  line 
NT14  16.1  90.8  0.85  G0.1 
Normal 
leukocytes 
PBL  97.3  80.5  0.23  20.1 
Neutrophil  1.6  1.5  ND II  G0.1 
The data are shown as mean of two independent experiments. 
* Triplicated aliquots of cells were cultured in serum-free media for 72 h with or without the addition of FN (50 #g/ml), and subjected to prolifera- 
tion and apoptosis assays. For culture of M07E ceUs, GM-CSF (10 ng/ml) was added to the media. 
* Cell proliferation was measured using a [3H-thymidine incorporation assay. The effect of FN on cell proliferation was expressed as stimulation 
index (SI); SI  =  (thymidine incorporation  [cpm] with FN)/(thymidine  incorporation  [cpm] without FN). 
S Ceils were stained with PI, and their nuclear DNA content was analyzed by a FACScan  |  (40). The cells whose DNA content was G 2 N were 
in apoptosis. The results show the increase in the proportion of apoptotic cells after treatment  with FN. 
II Ceil enumeration assay did show,  however,  that viable cell numbers of neutrophils were not affected by 72-h treatment  with FN. 
was considered to result from the induction of apoptosis, be- 
cause the treatment of M07E cells with FN induced oligo- 
nucleosomal DNA fragmentation and chromatin condensa- 
tion even in the presence of GM-CSF or SCF. 
The functions of FN on a variety of hematopoietic cells 
are known to be mediated through binding of FN to two 
VLA integrins,  VLA4 and VLA5 (18, 20-24).  Recently, a 
large number of investigators have examined the expression 
and function of  VLA4 and VLA5 in routine and human he- 
matopoietic stem or progenitor cells (25, 37, 44-50). For ex- 
ample, Williams et al. (47) have found that day 12 CFU spleen 
(CSF-S12)  expresses VLA4, and that the adhesion of routine 
hematopoietic stem cells with stromal ceil ECM is partly medi- 
ated through interaction between VLA4 and the CS-1 por- 
tion of FN (47).  In addition  to murine hematopoietic stem 
cells,  human primitive hematopoietic progenitor  cells have 
also been demonstrated to adhere to the RGDS-independent 
heparin-binding fragment of FN (48). Miyake et al. (49) have 
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progenitor cells to marrow stromal cells, whereas its interac- 
tion is not mediated by FN but by vascular cell adhesion mol- 
ecule 1 that is expressed on stromal cells. Also, they have 
demonstrated that lymphopoiesis  in a murine long-term cul- 
ture is abrogated by the addition of anti-VLA4 mAb, sug- 
gesting a functional requirement for this adhesion interac- 
tion  (50).  Thus,  although VLA4-mediated adhesion and 
growth of hematopoietic stem or progenitor cells has been 
extensively studied, the functional significance of VLA5 in 
the growth control of hematopoietic stem or progenitor cells 
remains elusive. 
Our data suggest that VLA5 may be involved in the growth 
control of hematopoietic cells through interaction with FN. 
Both growth inhibition and apoptosis induced by FN in M07E 
cells were substantially abolished by the treatment with ei- 
ther anti-FN Ab or anti-VLA5-oz mAb, but not with anti- 
VLA4-c~ mAb. Also, the addition of a GKGDSP peptide was 
found to result in significant abrogation of the effects of FN 
on M07E cells, whereas little or no effect was obtained by 
the incubation with a GRGESP peptide that was used as a 
control  In our preliminary study, it has been noted that 
growth inhibition or apoptosis of M07E cells can be gener- 
ated by a RGD sequence-containing 120-kD fragment of FN 
at a level almost similar to that of native FN, but not by 
either a 45-kD FN fragment of the gdatin binding domain 
or a 40-kD FN fragment of the heparin binding domain con- 
taining CS-1  region.  In  addition,  despite little effect  of 
FN-VLA5 interaction on a fibroblast  cell line (NTI4), FN 
could induce growth suppression or  apoptosis in VLA5- 
positive PBL and hematopoietic cell lines other than M07E 
cells. By contrast, FN had no activity in inducing growth 
suppression or apoptosis in any of the VLA5-negative hema- 
topoietic cell lines or in neutrophils that were lacking in VLA5 
expression. These results suggest that the interaction between 
FN and VLA5 may be important for FN-induced growth 
inhibition or apoptosis in hematopoietic ceils such as M07E 
cells. Furthermore, these results raise the possibility that the 
FN-VLA5 interaction may contribute, at least in part, to nega- 
tive regulation of hematopoiesis in vivo, although it remains 
to be determined whether the FN-VLA5 interaction has 
similar effects on normal hematopoietic stem or progenitor 
calls. 
The expression level of some integrins, including VLAS, 
is known to be diminished in oncogenic transformed cells 
(51). Moreover, there is evidence suggesting that neoplasmic 
transformation results in reduced binding of FN to integrins 
even when integrin expression is not affected (52). Giancotti 
and Kuoslahti overexpressed human VLA5 in transformed 
CHO  ceils, and examined the proliferative  potential and 
tumorigenicity of the overexpressor cells (53). They found 
that the overexpressor cells deposited more FN in their ECM 
than control CHO ceils, reduced the ability to grow in both 
liquid and semisdid cultures, and lost the ability to form 
tumors when injected into nude mouse (53). Although the 
mechanism for the growth suppression in the overe~ressor 
cells is not characterized,  these results provide an additional 
support for the idea that VLA5 may play a role in the control 
of cell growth. Also, it is possible that the defective interac- 
tion between FN and VLA5 may result in failure to provide 
negative signal to neoplasmic cells, thereby participating in 
the abnormal growth of the cells. 
Although this study provides unique evidence for the in- 
volvement of the FN-VLA5 interaction in the induction of 
apoptosis, the mechanisms  responsible for apoptosis in MO7E 
cells remain to be ducidated. Apoptosis is a normal physio- 
logical process that occurs in most animal tissues at some 
stage of development, and is thought to play a role in the 
maintenance of cell numbers at homeostatic levels by com- 
peting for proliferation or survival signals (for reviews see 
references 54 and 55). In the case of factor-dependent hema- 
topoietic call lines, it is well known that apoptosis can be 
prevented by hematopoietic growth factors that are essential 
for proliferation or survival of the cells (56). In this study, 
the pretreatment of M07E cells with FN did not have any 
effect on tyrosine phosphorylation of p93 and KitK that have 
shown to be phosphorylated on tyrosine by GMoCSF and 
SCF in a dose-dependent manner (34, 35). This suggests that 
the FN-induced apoptosis was not attributabh to the inhibi- 
tory effect of FN on very early steps, indnding ligand binding, 
in signal transduction from the GM-CSF and SCF receptors. 
It has recently been demonstrated that the kl-2 and c-m  F 
oncoproteins and the tumor suppressor p53 regulate apop- 
tosis (57). In some target cells, furthermore, the stimulation 
of TNF receptor or the Fas/APO-1 antigen can lead to call 
death by apoptosis (57, 58). In addition, some signaling mol- 
ecules, such as intracellular Ca  2  +, cAMP, and protein kinase 
C, have been suggested to be involved in the regulation of 
apoptosis (57). Also, recent studies on integrins indicate that 
they are capable of transducing a variety of signals into the 
cell, including protein tyrosine phosphorylation, increases in 
cytoplasmic pH,  changes in intracellular Ca  2+  or  cAMP 
levels, activation of the Na/H antiportor, and induction of 
gene expressions (59-64).  It is therefore possible that the sig- 
naling molecule(s) described above may be responsible for 
the induction of apoptosis in M07E cells. Experiments are 
currently in progress to identify the VLA5-mediated signal 
transduction molecule(s) that is involved in induction of apop- 
tosis. Clear and decisive information from such studies should 
not only lead to a more precise understanding of mechanisms 
underlying regulation of normal and abnormal hematopoi- 
esis, but also should suggest novel therapeutic procedures for 
patients with hematological disorders. 
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